314 related articles for article (PubMed ID: 34360692)
1. Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant
Hernández-Aristizábal I; Ocampo-Ibáñez ID
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360692
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis.
Shariati A; Dadashi M; Moghadam MT; van Belkum A; Yaslianifard S; Darban-Sarokhalil D
Sci Rep; 2020 Jul; 10(1):12689. PubMed ID: 32728110
[TBL] [Abstract][Full Text] [Related]
3. Vancomycin intermediate resistant
Adeoye-Isijola M; Olajuyigbe O; Adebola K; Coopoosamy R; Afolayan A
Afr Health Sci; 2020 Sep; 20(3):1109-1117. PubMed ID: 33402955
[TBL] [Abstract][Full Text] [Related]
4. Eradication of vancomycin-resistant Staphylococcus aureus on a mouse model of third-degree burn infection by melittin: An antimicrobial peptide from bee venom.
Bevalian P; Pashaei F; Akbari R; Pooshang Bagheri K
Toxicon; 2021 Aug; 199():49-59. PubMed ID: 34087287
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin Resistance in
McGuinness WA; Malachowa N; DeLeo FR
Yale J Biol Med; 2017 Jun; 90(2):269-281. PubMed ID: 28656013
[TBL] [Abstract][Full Text] [Related]
6. Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes.
Dietrich A; Steffens U; Gajdiss M; Boschert AL; Dröge JK; Szekat C; Sass P; Malik IT; Bornikoel J; Reinke L; Maček B; Franz-Wachtel M; Nieselt K; Harbig T; Scherlach K; Brötz-Oesterhelt H; Hertweck C; Sahl HG; Bierbaum G
Microbiol Spectr; 2022 Oct; 10(5):e0256722. PubMed ID: 36173303
[TBL] [Abstract][Full Text] [Related]
7. Multidrug and vancomycin resistance among clinical isolates of
Olufunmiso O; Tolulope I; Roger C
Afr Health Sci; 2017 Sep; 17(3):797-807. PubMed ID: 29085408
[TBL] [Abstract][Full Text] [Related]
8. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Tiwari HK; Sen MR
BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
[TBL] [Abstract][Full Text] [Related]
9. Activity of tick antimicrobial peptide from Ixodes persulcatus (persulcatusin) against cell membranes of drug-resistant Staphylococcus aureus.
Miyoshi N; Isogai E; Hiramatsu K; Sasaki T
J Antibiot (Tokyo); 2017 Feb; 70(2):142-146. PubMed ID: 27531221
[TBL] [Abstract][Full Text] [Related]
10. Reduced Susceptibility and Resistance to Vancomycin of Staphylococcus aureus: A Review of Global Incidence Patterns and Related Genetic Mechanisms.
Unni S; Siddiqui TJ; Bidaisee S
Cureus; 2021 Oct; 13(10):e18925. PubMed ID: 34812309
[No Abstract] [Full Text] [Related]
11. The combined antibacterial effects of sodium new houttuyfonate and berberine chloride against growing and persistent methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Li X; Wang P; Hu X; Zhang Y; Lu X; Li C; Nie T; Li G; Wang X; Pang J; Lu Y; Yang X; You X
BMC Microbiol; 2020 Oct; 20(1):317. PubMed ID: 33076836
[TBL] [Abstract][Full Text] [Related]
12. Effect of silver nanoparticles on vancomycin resistant Staphylococcus aureus infection in critically ill patients.
Elsawy S; Elsherif WM; Hamed R
Pathog Glob Health; 2021 Jul; 115(5):315-324. PubMed ID: 33872131
[TBL] [Abstract][Full Text] [Related]
13. Development of an Amplicon Nanopore Sequencing Strategy for Detection of Mutations Conferring Intermediate Resistance to Vancomycin in Staphylococcus aureus Strains.
Moller AG; Petit RA; Davis MH; Read TD
Microbiol Spectr; 2023 Feb; 11(1):e0272822. PubMed ID: 36688645
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
15. β-Lactam Combinations with Vancomycin Show Synergistic Activity against Vancomycin-Susceptible Staphylococcus aureus, Vancomycin-Intermediate S. aureus (VISA), and Heterogeneous VISA.
Tran N; Rybak MJ
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555635
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the Vancomycin Resistance in
Salah NM; Saafan AE; Salem EH; El Rabey HA; Alsieni MA; Alatawi FA; Alalawy AI; Abeer Mohammed AB
Biomed Res Int; 2022; 2022():7380147. PubMed ID: 35535039
[No Abstract] [Full Text] [Related]
17. Genotyping of enterotoxigenic methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) among commensal rodents in North Sinai, Egypt.
Eidaroos NH; Youssef AI; El-Sebae A; Enany ME; Farid DS
J Appl Microbiol; 2022 Mar; 132(3):2331-2341. PubMed ID: 34297868
[TBL] [Abstract][Full Text] [Related]
18. Emerging resistance mechanisms for 4 types of common anti-MRSA antibiotics in Staphylococcus aureus: A comprehensive review.
Liu WT; Chen EZ; Yang L; Peng C; Wang Q; Xu Z; Chen DQ
Microb Pathog; 2021 Jul; 156():104915. PubMed ID: 33930416
[TBL] [Abstract][Full Text] [Related]
19. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
Ghahremani M; Jazani NH; Sharifi Y
J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of vancomycin resistance in Staphylococcus aureus.
Gardete S; Tomasz A
J Clin Invest; 2014 Jul; 124(7):2836-40. PubMed ID: 24983424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
